KBC Group’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,462
| Closed | -$434K | – | 1871 |
|
|
2023
Q4 | $434K | Sell |
6,462
-111
| -2% | -$7.73K | ﹤0.01% | 757 |
|
|
2023
Q3 | $492K | Sell |
6,573
-395
| -6% | -$35K | ﹤0.01% | 739 |
|
|
2023
Q2 | $642K | Hold |
6,968
| – | – | ﹤0.01% | 739 |
|
|
2023
Q1 | $722K | Buy |
6,968
+4,639
| +199% | +$514K | ﹤0.01% | 741 |
|
|
2022
Q4 | $269K | Sell |
2,329
-3,572
| -61% | -$416K | ﹤0.01% | 887 |
|
|
2022
Q3 | $639K | Buy |
5,901
+551
| +10% | +$79K | ﹤0.01% | 723 |
|
|
2022
Q2 | $966K | Buy |
5,350
+33
| +0.6% | +$5.9K | ﹤0.01% | 668 |
|
|
2022
Q1 | $908K | Sell |
5,317
-118
| -2% | -$22.2K | ﹤0.01% | 713 |
|
|
2021
Q4 | $1.14M | Sell |
5,435
-2,109
| -28% | -$436K | ﹤0.01% | 703 |
|
|
2021
Q3 | $1.45M | Hold |
7,544
| – | – | 0.01% | 712 |
|
|
2021
Q2 | $2.13M | Hold |
7,544
| – | – | 0.01% | 652 |
|
|
2021
Q1 | $1.6M | Sell |
7,544
-211
| -3% | -$50.5K | 0.01% | 687 |
|
|
2020
Q4 | $1.52M | Buy |
7,755
+5,529
| +248% | +$977K | 0.01% | 691 |
|
|
2020
Q3 | $366K | Hold |
2,226
| – | – | ﹤0.01% | 852 |
|
|
2020
Q2 | $309K | Sell |
2,226
-1,000
| -31% | -$91.8K | ﹤0.01% | 923 |
|
|
2020
Q1 | $202K | Sell |
3,226
-11,261
| -78% | -$1.03M | ﹤0.01% | 1028 |
|
|
2019
Q4 | $1.59M | Buy |
14,487
+1,000
| +7% | +$96.8K | 0.01% | 744 |
|
|
2019
Q3 | $1.4M | Hold |
13,487
| – | – | 0.01% | 752 |
|
|
2019
Q2 | $1.73M | Hold |
13,487
| – | – | 0.01% | 646 |
|
|
2019
Q1 | $1.72M | Buy |
13,487
+3,805
| +39% | +$483K | 0.01% | 658 |
|
|
2018
Q4 | $1.21M | Sell |
9,682
-32,665
| -77% | -$5.59M | 0.01% | 684 |
|
|
2018
Q3 | $9.38M | Buy |
42,347
+22,149
| +110% | +$4.49M | 0.07% | 305 |
|
|
2018
Q2 | $3.23M | Hold |
20,198
| – | – | 0.03% | 497 |
|
|
2018
Q1 | $1.89M | Hold |
20,198
| – | – | 0.02% | 597 |
|
|
2017
Q4 | $1.41M | Hold |
20,198
| – | – | 0.01% | 691 |
|
|
2017
Q3 | $1.2M | Sell |
20,198
-902
| -4% | -$44.9K | 0.01% | 749 |
|
|
2017
Q2 | $875K | Buy |
21,100
+2,454
| +13% | +$107K | 0.01% | 816 |
|
|
2017
Q1 | $827K | Buy |
18,646
+4,952
| +36% | +$213K | 0.01% | 930 |
|
|
2016
Q4 | $570K | Buy |
+13,694
| New | +$551K | 0.01% | 1004 |
|
|
2015
Q4 | – | Sell |
-7,364
| Closed | -$198K | – | 1296 |
|
|
2015
Q3 | $198K | Sell |
7,364
-9,254
| -56% | -$270K | ﹤0.01% | 1006 |
|
|
2015
Q2 | $537K | Sell |
16,618
-4,865
| -23% | -$154K | 0.01% | 873 |
|
|
2015
Q1 | $644K | Hold |
21,483
| – | – | 0.01% | 842 |
|
|
2014
Q4 | $721K | Buy |
+21,483
| New | +$669K | 0.01% | 845 |
|
Other funds holding MED
KBC Group's MED Position: Q1 2024 in Review
KBC Group sold out of Medifast (MED) in Q1 2024, closing a stake of 6,462 shares — an estimated $434K sold.
KBC Group first reported a position in MED in Q4 2014 and held it in 33 quarters. The position peaked at $9.38M in Q3 2018. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.
- KBC Group reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
- KBC Group sold 6,462 Medifast shares in Q1 2024, an estimated $434K.
- KBC Group first reported a position in Medifast in Q4 2014 and held it in 33 quarters.
- KBC Group's Medifast position peaked at $9.38M in Q3 2018.
- 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.
Based on KBC Group's 13F filing for Q1 2024, filed 8 May 2024.